Journal of Oncology / 2011 / Article / Fig 3

Research Article

Peroxisome Proliferator-Activated Receptor-γ Ligands Alter Breast Cancer Cell Motility through Modulation of the Plasminogen Activator System

Figure 3

Ciglitazone decreases PAI-1 expression in MCF-10A and MCF-10CA1 cells and is not reversed by PPAR-γ antagonist pretreatment. Conditioned media from cells treated with ciglitazone (0–5 μM), in the absence and presence of 5 μM GW9662, was concentrated and 10 μg total protein was separated by SDS-PAGE on a 10% polyacrylamide gel. Proteins were then transferred to PVDF membrane and probed for PAI-1 (rabbit antihuman PAI-1 antiserum) as detailed under Section 2.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.